Public Employees Retirement Association of Colorado cut its position in shares of DaVita HealthCare Partners Inc. (NYSE:DVA) by 0.3% during the second quarter, according to its most recent filing with the SEC. The firm owned 32,333 shares of the company’s stock after selling 109 shares during the period. Public Employees Retirement Association of Colorado’s holdings in DaVita HealthCare Partners were worth $2,094,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of DVA. BlackRock Inc. boosted its stake in shares of DaVita HealthCare Partners by 2,315.8% in the first quarter. BlackRock Inc. now owns 12,892,477 shares of the company’s stock worth $876,303,000 after buying an additional 12,358,806 shares during the last quarter. Park West Asset Management LLC boosted its stake in shares of DaVita HealthCare Partners by 88.8% in the first quarter. Park West Asset Management LLC now owns 1,856,516 shares of the company’s stock worth $126,187,000 after buying an additional 873,064 shares during the last quarter. Tudor Investment Corp ET AL purchased a new stake in shares of DaVita HealthCare Partners during the first quarter worth about $31,376,000. PGGM Investments purchased a new stake in shares of DaVita HealthCare Partners during the second quarter worth about $28,598,000. Finally, First Trust Advisors LP boosted its stake in shares of DaVita HealthCare Partners by 472.2% in the first quarter. First Trust Advisors LP now owns 468,353 shares of the company’s stock worth $31,834,000 after buying an additional 386,499 shares during the last quarter. 84.32% of the stock is currently owned by institutional investors.

DaVita HealthCare Partners Inc. (NYSE DVA) opened at 56.52 on Thursday. The firm has a market cap of $10.81 billion, a price-to-earnings ratio of 8.61 and a beta of 0.89. DaVita HealthCare Partners Inc. has a 52 week low of $54.50 and a 52 week high of $70.56. The company has a 50-day moving average of $63.37 and a 200-day moving average of $65.78.

DaVita HealthCare Partners (NYSE:DVA) last posted its quarterly earnings results on Tuesday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.02. DaVita HealthCare Partners had a net margin of 8.68% and a return on equity of 14.02%. The company had revenue of $3.88 billion for the quarter, compared to analyst estimates of $3.82 billion. During the same quarter in the previous year, the firm posted $1.01 earnings per share. The company’s quarterly revenue was up 4.3% compared to the same quarter last year. Equities research analysts forecast that DaVita HealthCare Partners Inc. will post $3.57 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This article was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.watchlistnews.com/davita-healthcare-partners-inc-nysedva-shares-sold-by-public-employees-retirement-association-of-colorado/1467043.html.

DVA has been the topic of a number of research analyst reports. Goldman Sachs Group, Inc. (The) reaffirmed a “sell” rating and issued a $62.00 target price on shares of DaVita HealthCare Partners in a report on Thursday, May 25th. Zacks Investment Research upgraded shares of DaVita HealthCare Partners from a “hold” rating to a “buy” rating and set a $77.00 price target on the stock in a research note on Tuesday, April 18th. Jefferies Group LLC lowered shares of DaVita HealthCare Partners from a “buy” rating to a “hold” rating and upped their price target for the company from $64.89 to $70.00 in a research note on Monday, June 26th. BidaskClub lowered shares of DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a research note on Saturday, July 8th. Finally, TheStreet lowered shares of DaVita HealthCare Partners from a “b” rating to a “c+” rating in a research note on Wednesday, August 2nd. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $68.89.

In other news, CEO Javier Rodriguez sold 1,294 shares of the business’s stock in a transaction that occurred on Monday, May 15th. The shares were sold at an average price of $66.21, for a total value of $85,675.74. Following the sale, the chief executive officer now owns 99,111 shares of the company’s stock, valued at $6,562,139.31. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 2.10% of the company’s stock.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita HealthCare Partners Inc. (NYSE:DVA).

Institutional Ownership by Quarter for DaVita HealthCare Partners (NYSE:DVA)

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.